What is 10-Deacetylbaccatin III - Global Market?
10-Deacetylbaccatin III is a crucial organic compound that plays a significant role in the global market. It is a precursor in the biosynthesis of the anti-cancer drug paclitaxel (Taxol). This compound is extracted from the bark and needles of the European yew tree, and it is used in the production of semi-synthetic taxanes. The global market for 10-Deacetylbaccatin III is vast and diverse, with numerous applications in various sectors. However, the primary use of this compound is in the production of the anti-cancer drugs Docetaxel and Paclitaxel. These drugs are used in chemotherapy to treat various types of cancer, including breast, ovarian, and lung cancers. The demand for these drugs is high, and as a result, the market for 10-Deacetylbaccatin III is also robust.
Above 95%, Above 98.0%, Others in the 10-Deacetylbaccatin III - Global Market:
The global market for 10-Deacetylbaccatin III is segmented based on its purity levels, which include Above 95%, Above 98.0%, and Others. The Above 95% segment holds a significant share in the market due to its extensive use in the production of anti-cancer drugs. The Above 98.0% segment is also gaining traction due to its superior quality and efficacy. The Others segment includes 10-Deacetylbaccatin III with purity levels below 95%. This segment is also crucial as it caters to various other applications in the market. The global market for 10-Deacetylbaccatin III is highly competitive, with the top three manufacturers holding over 50% of the market share.
Production of Docetaxel, Production of Paclitaxel, Others in the 10-Deacetylbaccatin III - Global Market:
The global market outlook for 10-Deacetylbaccatin III is promising. The compound has been found to inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM. This discovery has opened up new avenues for the use of this compound in the medical field. The global 10-Deacetylbaccatin III market was valued at US$ 68 million in 2022 and is expected to reach US$ 89 million by 2029. This growth is attributed to a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2029. The market is dominated by the top three manufacturers who hold over 50% of the market share.
| Report Metric | Details |
| Report Name | 10-Deacetylbaccatin III - Market |
| Forecasted market size in 2029 | US$ 89 million |
| CAGR | 3.9% |
| Forecasted years | 2023 - 2029 |
| Global 10-Deacetylbaccatin III market, by region: |
|
| Global 10-Deacetylbaccatin III market, Segment by Type: |
|
| Global 10-Deacetylbaccatin III market, by Application |
|
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
